[Prognosis after late versus early nonfatal myocardial infarction]

A Sajadieh1, J F Hansen, L S Mortensen

  • 1H:S Bispebjerg Hospital, kardiologisk klinik, og UNI-C Aarhus.

Ugeskrift for Laeger
|February 26, 2000
PubMed

Insights

Recurrent myocardial infarction (RMIs) occurring later than one year after an initial heart attack carry a prognosis as grave as those within the first year. This study found no significant difference in mortality rates, highlighting the consistent risk of recurrent events.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • Nonfatal recurrent myocardial infarction (RNMI) is a significant predictor of patient outcomes.
  • Existing research primarily focuses on RNMI within the first year post-index infarction.
  • Prognosis following late RNMI remains under-investigated.

Purpose of the Study:

  • To investigate the prognosis of nonfatal recurrent myocardial infarction (RNMI) based on the timing of its occurrence after an index myocardial infarction.
  • To compare the mortality rates associated with early (first year) versus late (second to fourth year) RNMI.

Main Methods:

  • A cohort of 3,867 unselected patients under 76 years with acute myocardial infarction was studied.
  • Kaplan-Meier method was used for mortality estimation.
  • Tarone-Ware test was employed to evaluate differences in mortality rates.

Main Results:

  • 13.6% of patients experienced RNMI within the first year, with a 23.7% one-year mortality rate.
  • 5.4%, 4.2%, and 3.8% experienced RNMI in the second, third, and fourth years, respectively.
  • One-year mortality rates for late RNMI were 24.1% (year 2), 17.5% (year 3), and 22.8% (year 4).
  • No statistically significant difference in mortality rates or standardized mortality ratios was found between early and late RNMI groups (p = 0.12).

Conclusions:

  • Late and early nonfatal recurrent myocardial infarctions (RNMIs) share a similarly grave prognosis.
  • The timing of RNMI after an index infarction does not significantly alter the associated mortality risk.
  • Patients experiencing RNMI, regardless of timing, face a substantial and consistent risk of death.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...